Clinical Trial Update: Efficacy of Fluoxetine Against Seizure-induced Central Apneas [Phase 3]

View source ↗

Summary

Phase 3 trial assessing fluoxetine for reducing seizure-induced central apneas in epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Epilepsy, Ictal/Post-ictal Hypoxemia | Phase 3 | Status: COMPLETED